• Latest Posts

Legend Biotech new drug application approved in China

First CAR-T technology trial for patients with T-cell leukemia subtype authorized

Anocca secures €25M to develop next-generation T-cell therapies for cancer

Etcembly reveals breakthrough in optimizing TCR assets

PDC*line Pharma presents first immunological results from trial with PDC*lung01

Laevoroc Oncology pushes for relapsed leukemia cure


AstraZeneca splashes out up to $320M on T-cell receptor therapy company

Touchlight receives new grant to further develop doggybone DNA vaccine platform

BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry

Significant therapeutic potential of OSE Immunotherapeutics’ CLEC-1 published

Tevogen Bio to investigate T cell therapy in long Covid

Virax Biolabs introduces flu, Covid-19 and RSV rapid test kits